Canada loses another $2M in emergency drugs after freezer failure

Canada's public health agency says a freezer malfunction destroyed about $2 million in drugs held in the National Emergency Strategic Stockpile — the second such loss in a year, after a $20-million loss last year. The auditor general flagged long-standing weaknesses in stockpile management in October.
The Public Health Agency of Canada says a mechanical failure in a freezer destroyed about $2 million worth of drugs held in the National Emergency Strategic Stockpile. It is the second time in a year that a freezer failure has cost the stockpile drugs — a similar incident last year destroyed $20 million in pharmaceuticals. The figure appears in the federal public accounts published earlier this fall, first reported by The Canadian Press on November 21.
Auditor general flagged stockpile problems a month ago
Auditor General Karen Hogan reported to Parliament on October 29 that the agency had "not effectively managed" the National Emergency Strategic Stockpile, with "persistent weaknesses" in inventory and warehouse management. In 2025–26 the agency wrote off $331 million in expired or damaged medical supplies — about a quarter of the stockpile's value — and as of March 31, 2026, warehouses still held about 84 million expired items, 97 percent of them personal protective equipment, much of it bought during the COVID-19 pandemic. The auditor general's office confirmed both freezer losses are included in the $331-million figure.
Drugs were for responding to a biological threat; identity withheld
Health Canada spokesperson Hélène-Annie Lavoie said the latest loss involved a small portion of a specific drug treatment for responding to a biological threat. "A mechanical failure prevented a freezer from maintaining its required temperature, which led to a small portion of a stockpiled drug treatment being exposed to temperatures outside the required storage requirements," she said. The agency would not identify the drug, citing national security.
The audit found that more than $20 million in pharmaceuticals had to be discarded in 2025 because of a lack of preventive freezer maintenance, insufficient freezer space and inadequate temperature monitoring — deficiencies first identified in 2022 and 2023 that were not corrected in time. Of the 14 corrective actions in the agency's stockpile management plan, only five had been completed by March 2026.
Stockpile still answered every provincial request, but pressure to reform grows
The auditor general also noted that the agency answered all 81 requests for medical supplies from provincial, territorial and federal bodies in 2024–25 and 2025–26. The stockpile's value fell from $1.27 billion on April 1, 2025, to $1.07 billion a year later.
Conservative health critic Raquel Dancho raised the audit in Question Period on November 2, saying deficiencies identified years ago remained unresolved and put Canada's ability to respond to the next public health emergency in doubt. The agency has accepted the auditor general's recommendations, including setting evidence-based inventory targets, disposing of excess stock and prioritizing warehouse repairs by risk.
N環球 
💬 Comments
No comments yet. Be the first!